Literature DB >> 23303966

Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children.

Anne A Gershon1, Jason Chen, Larry Davis, Clarissa Krinsky, Robert Cowles, Ross Reichard, Michael Gershon.   

Abstract

Despite vaccination, varicella-zoster virus (VZV) remains an important pathogen. We investigated VZV latency in autopsy specimens from vaccinees, in gastrointestinal tissue removed surgically, and in a guinea pig model. We propose that retrograde transport from infected skin and viremia deliver VZV to neurons in which it becomes latent. Wild type (WT) VZV was found to be latent in many ganglia of vaccinated children with no history of varicella, suggesting that subclinical infection with WT-VZV occurs with subsequent viremic dissemination. The 30% to 40% rate of WT-VZV zoster reported in vaccinees and occasional trigeminal zoster due to vaccine type VZV (vOka) are consistent with viremic delivery of VZV to multiple ganglia. Most human intestinal specimens contained latent VZV within neurons of the enteric nervous system (ENS). Induction of viremia in guinea pigs led to VZV latency throughout the ENS. The possibility VZV reactivation in the ENS is an unsuspected cause of gastrointestinal disease requires future investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23303966      PMCID: PMC3540599     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  24 in total

1.  Effectiveness of 2 doses of varicella vaccine in children.

Authors:  Eugene D Shapiro; Marietta Vazquez; Daina Esposito; Nancy Holabird; Sharon P Steinberg; James Dziura; Philip S LaRussa; Anne A Gershon
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

2.  Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.

Authors:  Barbara A Pahud; Carol A Glaser; Cornelia L Dekker; Ann M Arvin; D Scott Schmid
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

Review 3.  Rodent models of varicella-zoster virus neurotropism.

Authors:  Jeffrey I Cohen
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 4.  Varicella-zoster virus: prospects for control.

Authors:  A A Gershon
Journal:  Adv Pediatr Infect Dis       Date:  1995

5.  The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.

Authors:  I Hardy; A A Gershon; S P Steinberg; P LaRussa
Journal:  N Engl J Med       Date:  1991-11-28       Impact factor: 91.245

6.  Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia.

Authors:  C S Robertson; B A Martin; M Atkinson
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

7.  Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.

Authors:  P LaRussa; O Lungu; I Hardy; A Gershon; S P Steinberg; S Silverstein
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  Varicella zoster gastritis in a bone marrow transplant recipient.

Authors:  W G McCluggage; J D Fox; K E Baillie; P V Coyle; F G Jones; M D O'Hara
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

9.  A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors.

Authors:  O Lungu; X W Sun; T C Wright; A Ferenczy; R M Richart; S Silverstein
Journal:  Obstet Gynecol       Date:  1995-03       Impact factor: 7.661

10.  Varicella zoster virus (VZV) infects and establishes latency in enteric neurons.

Authors:  Jason J Chen; Anne A Gershon; Zhishan Li; Robert A Cowles; Michael D Gershon
Journal:  J Neurovirol       Date:  2011-12-22       Impact factor: 3.739

View more
  45 in total

Review 1.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

Review 2.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

3.  THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

Review 4.  Varicella Virus Vaccination in the United States.

Authors:  Jana Shaw; Anne A Gershon
Journal:  Viral Immunol       Date:  2017-11-27       Impact factor: 2.257

5.  Varicella Zoster Virus and Giant Cell Arteritis.

Authors:  Anne A Gershon; Michael Gershon
Journal:  J Infect Dis       Date:  2016-03-31       Impact factor: 5.226

6.  Enteric Nervous System: Neuropathic Gastrointestinal Motility.

Authors:  Jackie D Wood
Journal:  Dig Dis Sci       Date:  2016-07       Impact factor: 3.199

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Varicella-zoster virus (VZV) infection as a possible cause of Ogilvie's syndrome in an immunocompromised host.

Authors:  Miguel F Carrascosa; José R Salcines-Caviedes; Javier Gómez Román; Marta Cano-Hoz; Marta Fernández-Ayala; Elena Casuso-Sáenz; Ismael Abascal-Carrera; Ana Campo-Ruiz; Marta Cobo Martín; Ainhoa Díaz-Pérez; Pablo González-Gutiérrez; José M Aguado
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

9.  Varicella-zoster virus and herpes simplex virus 1 can infect and replicate in the same neurons whether co- or superinfected.

Authors:  Anna Sloutskin; Michael B Yee; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 10.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.